SynchroPET
Stony Brook
About SynchroPET
We build the smallest Positron Emission Tomography (PET) Scanners in medical imaging and research. Our first device promises to disrupt the nuclear imaging market by providing a non invasive input function that makes all PET scanners more quantitative and better at diagnosis and treatment of diseases like cancer, alzheimers, and parkinson's. This new quantitative data opens up and accelerates new possibilities in personalized medical treatments and cures.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.5M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Jan 2021)
- Website: synchropet.com
- Phone: (631) 775-8909
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/synchropet-163031 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.